Medifast (MED) Current Deferred Revenue (2018 - 2020)

Medifast (MED) has 3 years of Current Deferred Revenue data on file, last reported at $7.6 million in Q4 2020.

• For the quarter ending Q4 2020, Current Deferred Revenue rose 75.54% year-over-year to $7.6 million; the trailing twelve-month figure through Dec 2020 stood at $7.6 million (up 75.54% YoY), and the FY2020 full-year result was $7.6 million, up 75.54% from the prior year.
• Current Deferred Revenue for Q4 2020 stood at $7.6 million, up from $4.3 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $7.6 million in Q4 2020 and bottomed at $2.8 million in Q4 2018.
• The 3-year median for Current Deferred Revenue is $4.3 million (2019), against an average of $4.9 million.
• The widest annual swing landed in 2019, when Current Deferred Revenue surged 54.92%; it then surged 75.54% in 2020.
• A 3-year view of Current Deferred Revenue shows it stood at $2.8 million in 2018, then soared by 54.92% to $4.3 million in 2019, then soared by 75.54% to $7.6 million in 2020.
• The last three Current Deferred Revenue figures came in at $7.6 million (Q4 2020), $4.3 million (Q4 2019), and $2.8 million (Q4 2018), per Business Quant data.

Peer Comparison